Genetic Technologies Ltd.
(NASDAQ : GENE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.25%68.680.0%$2146.62m
NVAXNovavax, Inc. 8.39%144.4696.5%$1227.57m
SRNESorrento Therapeutics, Inc. -4.77%12.392.8%$764.70m
GILDGilead Sciences, Inc. 0.78%68.711.0%$572.37m
AMGNAmgen, Inc. 0.25%239.461.3%$469.74m
REGNRegeneron Pharmaceuticals, Inc. 0.68%615.052.7%$387.39m
VRTXVertex Pharmaceuticals, Inc. 0.07%267.341.9%$353.41m
BIIBBiogen, Inc. 0.49%289.941.6%$351.80m
ILMNIllumina, Inc. -2.18%345.843.5%$344.11m
BNTXBioNTech SE -3.24%68.700.0%$341.59m
ATNMActinium Pharmaceuticals, Inc. -1.11%9.8013.3%$233.99m
VXRTVaxart, Inc. 1.27%9.210.0%$215.03m
EBSEmergent BioSolutions, Inc. -1.76%132.566.4%$195.90m
MCRBSeres Therapeutics, Inc. -3.92%27.463.6%$179.57m
ALXNAlexion Pharmaceuticals, Inc. 1.41%103.332.0%$165.38m

Company Profile

Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.